In turn, LIN28 proteins reduced overall liver damage, acting on NF‐κB and IL‐13 signalling pathways, suggesting a therapeutic effect of LSCEVs in liver diseases mediated by the let‐7/LIN28 axis (Mcdaniel et al., 2019). This evidence concerns the gene LIN28A and liver disorder.